Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2021 Nov 5;167(1):189–194. doi: 10.1007/s00705-021-05291-9

Molecular epidemiology of type I and II feline coronavirus from cats with suspected feline infectious peritonitis in China between 2019 and 2021

Lishan Lin 1,#, Dawei Yao 1,#, Lei Wu 1, Rubin Fan 1, Yang Liu 1, Zhenlei Zhou 1,
PMCID: PMC8570233  PMID: 34739587

Abstract

Feline infectious peritonitis (FIP) is one of the deadliest diseases of cats in China. In this study, 120 ascitic fluid samples from FIP-suspected cats were collected from veterinary hospitals in 21 provinces in China between 2019 and 2021. One hundred nine samples were positive for feline coronavirus (FCoV), with no feline immunodeficiency virus infections and one feline leukemia virus infection (1/109, 0.92%). The prevalence of FCoV was significantly associated with age (p < 0.01) and was not highly associated with gender, breed, geographical location, or viral coinfection (p > 0.01). One unique strain, SD/202012/003, contained a six-nucleotide deletion in the spike gene. Sequence analysis showed that 94.68% (89/94) of the isolates had a mutation of methionine to leucine at position 1058 in the spike protein. The epidemiological data obtained of FCoV in this study may be beneficial for clinical monitoring of FCoV in China.

Supplementary Information

The online version contains supplementary material available at 10.1007/s00705-021-05291-9.

Introduction

Feline infectious peritonitis (FIP) is a fatal disease with a high mortality rate, especially in kittens, that is typically characterized by granulomatous inflammatory lesions in several organs and/or protein‐rich serous effusion in body cavities [1]. The etiologic pathogen of FIP has been identified as feline infectious peritonitis virus (FIPV), which originated from feline enteric coronavirus (FECV) [2]. FIPV and FECV are biotypes of feline coronavirus (FCoV), a single-stranded positive-sense RNA virus belonging to the family Coronaviridae, order Nidovirales [3]. FCoV has two genotypes, FCoV-I and FCoV-II [4]. The latter genotype resulted from recombination between a type I FCoV and canine coronavirus (CCoV) [5].

FIP is a consequence of a viral infection. However, it is usually associated with several risk factors, such as age, environment, and viral coinfections. FIP occurs mostly in 6-month- to 2-year-old cats [6, 7]. This is possibly attributable to less-effective control of replication of FCoV in these animals [8]. Thus, critical mutations are more likely to appear. Furthermore, a multiple-cat environment is considered a significant risk factor for FIP because it increases the risk of FECV infection [9]. Recovery from FIP is generally dependent on the elimination of FECV infection. Moreover, it has been reported that cats with viral coinfections are more likely to develop FIP due to the immunosuppressive effect of feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) [1012].

Taking into consideration the sparse information related to FIPV in domestic cats in China, the aims of this study were (a) to carry out an epidemiological survey in China between 2019 and 2021 regarding age, breed, gender, and geographical location, (b) to determine the genotype of FCoV and the presence of viral coinfection with FeLV and FIV, (c) to identify amino acid substitutions at position 1058 in the spike protein, and (d) to investigate the genetic divergence of the identified FCoV isolates for the currently circulating coronaviruses.

Materials and methods

A total of 120 samples were collected from veterinary hospitals between 2019 and 2021, and basic information was recorded. The samples were tested for the presence of feline coronavirus and other viruses, after which the FCoV genotype was determined. Sanger sequencing was performed to identify the M1058L mutation in the S gene, and a phylogenetic tree was constructed for phylogenetic analysis. Further details are provided as a supplementary file.

Results

One hundred nine out of 120 samples tested positive for FCoV by PCR. Detailed information about the 120 samples is given in Supplementary Table S1. The percentage of sampling sites located in northern and southern China was 52.29% (57/109) and 47.71% (52/109), respectively. The percentage of male and female cats in this study was 53.21% (58/109) and 46.79% (51/109), respectively. The purebred and cross-breed cats accounted for 41.28% (45/109) and 58.72% (64/109), respectively. The age of the FIP-suspected cats ranged from 1 week to 67 months. The ??median?? age was 3 months, with a proportion of 16.51%. The percentage of cats less than 12 months and 24 months old was 91.74% and 97.25%, respectively. FIV was not detected in any of the samples, while one of the 109 FCoV-positive samples and one of the 11 FCoV-negative samples were positive for FeLV. The prevalence of FCoV was significantly associated with age (p = 0.003) and was not highly associated with gender (p = 0.731), breed (p = 0.268), geographical location (p = 0.908), or viral coinfection (p = 0.434) (Table 1).

Table 1.

Correlation of FCoV positivity with age, gender, breed, geographical location, and viral coinfections

Variable Number of positive samples Number of negative samples OR 95% CI p-value
Age
 <12 months 96 6 1.615 0.937–2.782 0.003
 ≥12 months 13 5 0.262 0.115–0.598
Gender
 Male 58 7 0.836 0.517–1.352 0.731
 Female 51 4 1.287 0.574–2.884
Breed
 Pure 45 7 0.649 0.394–1.069 0.268
 Cross 64 4 1.615 0.727–3.584
Geographical location
 North China 57 5 1.150 0.588–2.252 0.908
 South China 52 6 0.875 0.493–1.553
Viral coinfections
 FeLV positive 1 1 0.101 0.007–1.504 0.434
 FeLV negative 108 10 1.090 0.903–1.315

OR odds ratio, CI confidence interval

Partial S gene sequences were determined for 78 (71.56%, 78/109) of the samples (Supplementary Table S1). Sequence analysis indicated that the positive rate for FCoV I and FCoV II was 98.72% (77/78) and 1.28% (1/78), respectively. The nucleotide and amino acid sequence identity among the 77 FCoV I strains was 81.00%-100.00% and 82.1%-100%, respectively. The 77 type I strains exhibited 80.4%-89.3% nucleotide sequence identity and 80.4%-94.6% amino acid sequence identity to the type I FCoV reference strain C1Je. The nucleotide and amino acid sequence identity of the FCoV type II strain to the 77 identified type I strains was 52.9%-58.9% and 55.2%-67.2%, respectively. The FCoV type II strain exhibited 94.0% nucleotide and 98.2% amino acid sequence identity to the type II FCoV reference strain 79-1146. It is interesting to note that one strain, SD/202012/003, contained a six-nucleotide deletion compared with the other 76 FCoV I strains (Fig. 1).

Fig. 1.

Fig. 1

Alignment of a portion of the nucleotide sequence of the S gene, showing a six-nucleotide deletion in a type I FCoV strain

The partial S genes of 94 (94/109, 86.24%) samples were amplified to identify the mutation M1058L in the S gene. Sequence analysis showed that 89 (89/94, 94.68%) had a T (78/94, 82.98%) or C (11/94, 11.70%) at position 23,531, while five had an A (5/94, 5.32%) at the same position, indicating that 94.68% of the strains had a mutation from methionine to leucine at position 1058 in the spike gene.

Phylogenetic analysis of partial S genes of 78 FCoV strains showed that the phylogenetic tree was divided into 11 clusters of type I FCoV and one cluster of type II FCoV (Fig. 2). The type II FCoV strain AH/202007/002 exhibited the closest relationship to a FCoV strain from Taiwan and a raccoon dog coronavirus strain. Strain SD/202012/003 contained a six-nucleotide deletion in the spike gene, and two other strains, BJ/201811/MG892420 and BJ/201811/MG892451, had a different six-nucleotide deletion.

Fig. 2.

Fig. 2

Phylogenetic analysis of type I and II FCoV strains based on partial S gene sequences (168 bp)

Discussion

In this study, the percentage of FIP-suspected cats less than 12 months old and less than 24 months old was 91.74% and 97.25%, respectively, which is in agreement with a previous report. In this study, no significant correlation was found between FIP and breed or gender (p > 0.05). A previous study showed that breed and gender were not associated with FIP [13], but other studies have indicated that male sex was significantly correlated with FIP [6, 14]. There is also evidence of a predilection for FIP in some breeds [8]. Therefore, the data regarding risk factors for FIP are still controversial.

In this study, viral coinfection with FCoV was investigated as a potential risk factor. FIV was not detected in any of the samples, while only one FCoV-positive and one FCoV-negative sample were positive for FeLV. The prevalence rate of FIV has been reported to be approximately 10% in Hungary, Malaysia, and Ireland [1517]. However, the positive rate of FIV in China is only 1.3-1.5% [18, 19]. The reason for this difference is unclear. In Hungary, Malaysia, and Ireland, the positive rate of FeLV was reported to be 17.3%, 12.0%, and 10.4%, respectively, while the prevalence rate of FeLV in China was found to be 11.33% [20]. In this study, no significant association was found between FCoV infection and FIV or FeLV infection (p = 0.434). The possible reason may be the low morbidity rate, and more clinical samples were required.

The positive rate of FCoV I and FCoV II was 98.72% (77/78) and 1.28% (1/78), respectively, while the genotype of the remaining samples could not be determined due to a low viral load in the samples or possibly to mismatching between primers and templates. The results indicated that FCoV I is the dominant genotype in China, which is in agreement with what has been reported in Japan [14] and Malaysia [21]. Type II FCoVs, which are recombinants of a type I FCoV and CCoV, are still far less prevalent than type I FCoVs. There is little evidence that differences in infectivity, disease severity, or lethality are associated with the differences in prevalence of the two types of FCoV.

Studies focusing on differentiating between FECV and FIPV have been conducted mainly at the molecular level. Several studies have revealed that mutations in the 3C, 7a, and 7b genes may play an important role in the genotype switch [22, 23]. However, accurate detection methods need to be established to reliably distinguish these two biotypes of FCoV. One study indicated that 95.83% (23/24) of the ??viruses from animals with FIP?? had the amino acid substitution M1058L in the spike protein, while none of ??those from animals without FIP?? had this substitution, indicating that the substitution M1058L is correlated with FIP [24]. In this study, we found that 94.68% of the 94 samples had the M1058L mutation in the spike gene, which is consistent with previous studies [24, 25]. Thus, the M1058L substitution in the S gene could be an indicator of FIP.

A phylogenetic tree based on partial S sequences showed that 77 type I FCoV strains maintained genetic diversity, while only one type II FCoV strain exhibited a close relationship to a FCoV strain from Taiwan and a raccoon dog coronavirus strain. One study indicated that the above two strains, BJ/201811/MG892420 and BJ/201811/MG892451, with a six-nucleotide deletion in the spike gene were not reported in the current GenBank database [26]. The limited information currently available suggests that the six-nucleotide deletion may be one of the characteristics of Chinese regional type I FCoV strains. In this study, strain SD/202012/003 contained a different six-nucleotide deletion, which was also not recorded in the GenBank database. Therefore, this strain might also be Chinese regional type I FCoV strain.

This study was carried out to investigate the epidemiology of FCoV in China during 2019 to 2021 regarding age, breed, gender, geographical location, and viral coinfections. The prevalence of FCoV was significantly correlated with age (p < 0.01) but was not highly associated with gender, breed, geographical location, or viral coinfection (p > 0.01). Type I FCoV was more predominately detected than type II FCoV. More than 90% of the strains had a mutation from methionine to leucine at position 1058 in the spike protein, indicating that this could serve as an indicator of FIP. These data provide useful information about the epidemiology of FCoV in China.

Supplementary Information

Below is the link to the electronic supplementary material.

Author contributions

Conceptualization: LL, DY, and ZZ. Methodology: LL, DY. Software: YL. Validation: LW. Formal analysis: LW. Investigation: LL, DY. Resources: ZZ. Data curation: RF. Writing—original draft preparation: LL, DY. Writing—review & editing: LW, RF, YL. Visualization: LL, DY. Supervision: ZZ. Project administration: LL, DY, LW. Funding acquisition: ZZ.

Funding

This work was supported by the Fundamental Research Funds for the Central Universities (Grant Number KYZ202002).

Data availability

The data from this study are freely available in the GenBank database (https://www.ncbi.nlm.nig.gov/) under the accession numbers MW858252- MW858329.

Declarations

Conflict of interest

The authors declare that there is no conflict of interest.

Ethical approval

The study was approved by the Laboratory Animal Welfare and Ethics Committee of Nanjing Agricultural University. The study did not involve endangered or protected species. No specific permissions were required for location of samples because the samples were collected from public areas or non‐protected areas. The release of sampling information was approved by the cats’ owners.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Lishan Lin and Dawei Yao contributed equally to this work.

References

  • 1.Robison RL, Holzworth J, Gilmore CE. Naturally occurring feline infectious peritonitis: signs and clinical diagnosis. J Am Vet Med Assoc. 1971;158(Suppl 2):981–986. [PubMed] [Google Scholar]
  • 2.Pedersen NC. A review of feline infectious peritonitis virus infection: 1963–2008. J Feline Med Surg. 2009;11:225–258. doi: 10.1016/j.jfms.2008.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gonzalez JM, Gomez-Puertas P, Cavanagh D, Gorbalenya AE, Enjuanes L. A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae. Arch Virol. 2003;148:2207–2235. doi: 10.1007/s00705-003-0162-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Pedersen NC, Black JW, Boyle JF, Evermann JF, McKeirnan AJ, Ott RL. Pathogenic differences between various feline coronavirus isolates. Adv Exp Med Biol. 1984;173:365–380. doi: 10.1007/978-1-4615-9373-7_36. [DOI] [PubMed] [Google Scholar]
  • 5.Herrewegh AAPM, Smeenk I, Horzinek MC, Rottier PJM, de Groot RJ. Feline coronavirus type II strains 79–1683 and 79–1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J Virol. 1998;72:4508–4514. doi: 10.1128/Jvi.72.5.4508-4514.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Riemer F, Kuehner KA, Ritz S, Sauter-Louis C, Hartmann K. Clinical and laboratory features of cats with feline infectious peritonitis–a retrospective study of 231 confirmed cases (2000–2010) J Feline Med Surg. 2016;18:348–356. doi: 10.1177/1098612X15586209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hartmann K. Feline infectious peritonitis. Vet Clin N Am Small Anim Pract. 2005;35(39–79):vi. doi: 10.1016/j.cvsm.2004.10.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Worthing KA, Wigney DI, Dhand NK, Fawcett A, McDonagh P, Malik R, Norris JM. Risk factors for feline infectious peritonitis in Australian cats. J Feline Med Surg. 2012;14:405–412. doi: 10.1177/1098612X12441875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Foley JE, Poland A, Carlson J, Pedersen NC. Risk factors for feline infectious peritonitis among cats in multiple-cat environments with endemic feline enteric coronavirus. J Am Vet Med Assoc. 1997;210:1313–1318. [PubMed] [Google Scholar]
  • 10.Poland AM, Vennema H, Foley JE, Pedersen NC. Two related strains of feline infectious peritonitis virus isolated from immunocompromised cats infected with a feline enteric coronavirus. J Clin Microbiol. 1996;34:3180–3184. doi: 10.1128/JCM.34.12.3180-3184.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hardy WD., Jr Immunopathology induced by the feline leukemia virus. Springer Semin Immunopathol. 1982;5:75–106. doi: 10.1007/BF00201958. [DOI] [PubMed] [Google Scholar]
  • 12.Cotter SM, Hardy WD, Jr, Essex M. Association of feline leukemia virus with lymphosarcoma and other disorders in the cat. J Am Vet Med Assoc. 1975;166:449–454. [PubMed] [Google Scholar]
  • 13.Rissi DR. A retrospective study of the neuropathology and diagnosis of naturally occurring feline infectious peritonitis. J Vet Diagn Invest. 2018;30:392–399. doi: 10.1177/1040638718755833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Soma T, Wada M, Taharaguchi S, Tajima T. Detection of ascitic feline coronavirus RNA from cats with clinically suspected feline infectious peritonitis. J Vet Med Sci. 2013;75:1389–1392. doi: 10.1292/jvms.13-0094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Sivagurunathan A, Atwa AM, Lobetti R. Prevalence of feline immunodeficiency virus and feline leukaemia virus infection in Malaysia: a retrospective study. JFMS Open Rep. 2018;4:2055116917752587. doi: 10.1177/2055116917752587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Szilasi A, Dénes L, Krikó E, Heenemann K, Ertl R, Mándoki M, Vahlenkamp TW, Balka G. Prevalence of feline immunodeficiency virus and feline leukaemia virus in domestic cats in Hungary. JFMS Open Rep. 2019;5:2055116919892094. doi: 10.1177/2055116919892094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Szilasi A, Dénes L, Krikó E, Murray C, Mándoki M, Balka G. Prevalence of feline leukaemia virus and feline immunodeficiency virus in domestic cats in Ireland. Acta Vet Hung. 2021 doi: 10.1556/004.2020.00056. [DOI] [PubMed] [Google Scholar]
  • 18.Liu C, Liu Y, Qian P, Cao Y, Wang J, Sun C, Huang B, Cui N, Huo N, Wu H, Wang L, Xi X, Tian K. Molecular and serological investigation of cat viral infectious diseases in China from 2016 to 2019. Transbound Emerg Dis. 2020;67:2329–2335. doi: 10.1111/tbed.13667. [DOI] [PubMed] [Google Scholar]
  • 19.Zhang J, Wang L, Li J, Kelly P, Price S, Wang C. First molecular characterization of feline immunodeficiency virus in domestic cats from Mainland China. PLoS ONE. 2017;12:e0169739. doi: 10.1371/journal.pone.0169739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Cong W, Meng QF, Blaga R, Villena I, Zhu XQ, Qian AD. Toxoplasma gondII, Dirofilaria immitis, feline immunodeficiency virus (FIV), and feline leukemia virus (FeLV) infections in stray and pet cats (Felis catus) in northwest China: co-infections and risk factors. Parasitol Res. 2016;115:217–223. doi: 10.1007/s00436-015-4738-y. [DOI] [PubMed] [Google Scholar]
  • 21.Amer A, Siti Suri A, Abdul Rahman O, Mohd HB, Faruku B, Saeed S, Tengku Azmi TI. Isolation and molecular characterization of type I and type II feline coronavirus in Malaysia. Virol J. 2012;9:278. doi: 10.1186/1743-422x-9-278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Pedersen NC. An update on feline infectious peritonitis: virology and immunopathogenesis. Vet J. 2014;201:123–132. doi: 10.1016/j.tvjl.2014.04.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Vennema H, Poland A, Foley J, Pedersen NC. Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology. 1998;243:150–157. doi: 10.1006/viro.1998.9045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Sangl L, Matiasek K, Felten S, Gründl S, Bergmann M, Balzer HJ, Pantchev N, Leutenegger CM, Hartmann K. Detection of feline coronavirus mutations in paraffin-embedded tissues in cats with feline infectious peritonitis and controls. J Feline Med Surg. 2019;21:133–142. doi: 10.1177/1098612x18762883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Chang HW, Egberink HF, Halpin R, Spiro DJ, Rottier PJ. Spike protein fusion peptide and feline coronavirus virulence. Emerg Infect Dis. 2012;18:1089–1095. doi: 10.3201/eid1807.120143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Li C, Liu Q, Kong F, Guo D, Zhai J, Su M, Sun D. Circulation and genetic diversity of Feline coronavirus type I and II from clinically healthy and FIP-suspected cats in China. Transbound Emerg Dis. 2019;66:763–775. doi: 10.1111/tbed.13081. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

The data from this study are freely available in the GenBank database (https://www.ncbi.nlm.nig.gov/) under the accession numbers MW858252- MW858329.


Articles from Archives of Virology are provided here courtesy of Nature Publishing Group

RESOURCES